To evaluate the regulation of VWF in humans, we previously assessed serum levels in the population reported in this study and observed differential regulation of VWF, with higher levels in patients with CCD compared with HV, and patients with AIS/TIA having even higher levels than the CCD group [11]. The gene discussed is VWF; the disease is transient ischemic attack.